Enter the expert review stage!

Recently, the National Medical Insurance Administration issued an announcement that the list of declared drugs announced at the beginning of this month has been reviewed and revised, and the results of the review of the 2021 National Medical Insurance Drug List adjustment form have been formally formed .
The next step will be to organize expert review and other related work
.

The list of declared drugs announced at the beginning of this month has been reviewed and revised, and the results of the review of the 2021 National Medical Insurance Drug List Adjustment Form have been officially formed.
Expert review will be organized

According to the previous progress description, the expert review stage will be conducted from August to September :

The expert review stage is conducted from August to September

Comprehensive group review

Comprehensive group review

According to the company's application status, establish a database of drugs for review
.

Demonstration to determine the key points of the review technology

Professional group review

Professional group review

Organize experts to use evaluation indicators to demonstrate and evaluate drugs
.

At the same time, for the drugs to be negotiated, the main specifications of the negotiation, the reference drugs and the limited payment range are determined by argumentation

Comprehensive group argument

Comprehensive group argument

The expert opinions of the professional group were demonstrated, and the drug list was finally determined in five aspects: direct new transfer, negotiation new transfer, direct transfer, possible transfer, and adjustment of the limited payment scope
.

Feedback result

Feedback result

Feedback the expert review results to the applying company
.

Since then, the 9 to 10 month entered the negotiation phase , 10 to November publication of the results
.

Enter the negotiation stage from September to October, and announce the results from October to November

Attached original announcement:

Attached original announcement:

Announcement of the National Medical Security Administration on the Inquiry of the Results of the Review of the Adjustment Form of the National Medical Insurance Drug Catalogue in 2021

Announcement of the National Medical Security Administration on the Inquiry of the Results of the Review of the Adjustment Form of the National Medical Insurance Drug Catalogue in 2021

From July 30 to August 5, 2021, the Bureau announced to the public the "List of Drugs Applicable for the 2021 National Medical Insurance Drug Catalog Adjustment Passed the Preliminary Formal Examination"
.

Based on feedback from all parties, we reviewed and revised the results of related drugs, and formally formed the review results of the 2021 National Medical Insurance Drug Catalogue Adjustment Form.

In the next step, our bureau will organize and carry out expert review and other related work in accordance with the relevant requirements of the "Interim Measures for the Administration of Drugs for Basic Medical Insurance" and the "Work Plan for the 2021 National Medical Insurance Drug List Adjustment"
.

Companies are requested to pay attention to the "2021 National Medical Insurance Drug Catalogue Adjustment Application Module" in order to obtain relevant review, negotiation, and agreement information from the National Medical Insurance Bureau in a timely manner

National Medical Security Administration

August 27, 2021